Kolexia
Vignon Marguerite
Hématologie
Hôpital Cochin
Paris, France
97 Activités
5 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Myélome multiple Lymphomes Paraprotéinémies Leucémie aigüe myéloïde COVID-19 Tumeurs hématologiques Insuffisance rénale Leucémies Leucémie chronique lymphocytaire à cellules B

Industries

Abbvie
3 collaboration(s)
Dernière en 2023
A+A
2 collaboration(s)
Dernière en 2020
Janssen
2 collaboration(s)
Dernière en 2022
Pfizer
2 collaboration(s)
Dernière en 2023

Dernières activités

Digital Ischemia as a Rare Manifestation of C3 Glomerulopathy Associated With Monoclonal Gammopathy
Kidney international reports   13 décembre 2023
Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational study.
British journal of haematology   12 novembre 2023
RCHOP Plus High-Dose Methotrexate As First-Line Therapy in Large B-Cell Lymphoma with Testis Involvement
65th ASH Annual Meeting Abstracts   02 novembre 2023
Teclistamab in Relapsed Refractory Multiple Myeloma Patients on Dialysis: A French Experience
65th ASH Annual Meeting Abstracts   02 novembre 2023
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study.
Haematologica   01 octobre 2023
Subcutaneous azacitidine maintenance in transplantineligible patients with acute myeloid leukemia: a single-center retrospective study.
Haematologica   01 octobre 2023
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM).
Cancers   09 août 2023
Management of Gastro-Intestinal Toxicity of the Pi3 Kinase Inhibitor: Optimizing Future Dosing Strategies.
Cancers   13 avril 2023
Low Non Relapse Mortality and Good Hematological Response after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients with Renal Insufficiency at Transplant: A Prospective Société Francaise De Greffe De Moelle-Thérapie Cellulaire Observational Study
Annual Meeting Abstracts 2022   15 novembre 2022
Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era.
Viruses   27 octobre 2022